EcoDrugPlus

Opioid Receptor Kappa 1

Ensembl ID : ENSMOCG00000021359
Gene Symbol: OPRK1
3 Cross references
262 Possible Orthologues:

Opioid Receptor Mu 1

Ensembl ID : ENSMOCG00000009671
Gene Symbol: OPRM1
3 Cross references
214 Possible Orthologues:

Opioid Related Nociceptin Receptor 1

Ensembl ID : ENSMOCG00000000133
Gene Symbol: OPRL1
3 Cross references
199 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSMOCG00000002867
Gene Symbol: OXTR
3 Cross references
262 Possible Orthologues:

P21 (Rac1) Activated Kinase 4

Ensembl ID : ENSMOCG00000009611
Gene Symbol: PAK4
3 Cross references
163 Possible Orthologues:

Pancreatic Triacylglycerol Lipase

Ensembl ID : ENSMOCG00000006644
Gene Symbol: LOC101990038
3 Cross references
291 Possible Orthologues:

Pancreatic Triacylglycerol Lipase-Like

Ensembl ID : ENSMOCG00000022003
Gene Symbol: LOC101990333
2 Cross references
279 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSMOCG00000018080
Gene Symbol: PTH1R
3 Cross references
196 Possible Orthologues:

Peptidyl-Prolyl Cis-Trans Isomerase A

Ensembl ID : ENSMOCG00000002918
Gene Symbol: LOC101982342
2 Cross references
299 Possible Orthologues:

Peptidyl-Prolyl Cis-Trans Isomerase A-Like

Ensembl ID : ENSMOCG00000003363
Gene Symbol: LOC101990062
2 Cross references
299 Possible Orthologues:

Peptidyl-Prolyl Cis-Trans Isomerase A-Like

Ensembl ID : ENSMOCG00000019321
Gene Symbol: LOC101993850
2 Cross references
299 Possible Orthologues:

Peptidyl-Prolyl Cis-Trans Isomerase A-Like

Ensembl ID : ENSMOCG00000005189
Gene Symbol: LOC101996039
2 Cross references
299 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).